Drug intelligence / Profile preview

Lanjin

Development stage
Unknown
Lead developer
Hunan Zhongqi Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Lanjin (蓝金) is a prominent brand of pharmaceutical products developed and marketed by Hunan Zhongjia Pharmaceutical Development Co., Ltd., primarily targeting the common cold and respiratory infections. The brand encompasses a variety of formulations, including both Traditional Chinese Medicine (TCM) and western-style combination drugs. The most notable product under the Lanjin brand for 'wind-heat' syndrome is the **Lanjin Yinqiao Jiedu Tablet**, a classic TCM formula containing ingredients like Honeysuckle and Forsythia, which is used to alleviate fever, headache, and sore throat. Other significant products include **Lanjin Compound Paracetamol and Amantadine Hydrochloride Capsules** (a western medicine combination for general cold symptoms) and **Lanjin Xiao'er Kechuan Ling Keli** (a pediatric formulation for cough and asthma). These medications are widely utilized in China for the treatment of acute upper respiratory tract infections and associated syndromes.

Brand names
Lanjin蓝金
Other names
Yinqiao Jiedu Tablet银翘解毒片Compound Paracetamol and Amantadine Hydrochloride Capsules氨咖黄敏胶囊Ganmao Ling Keli感冒灵颗粒Xiao'er Kechuan Ling Keli小儿咳喘灵颗粒
02

Targets

CHRM2 (M2)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Lanjin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lanjin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call